Introduction
Asthma and chronic obstructive pulmonary disease (COPD) have a significant impact on patients' quality of life, and community pharmacists may be able to help improve asthma control. [1] [2] [3] Less is known about the impact of pharmacists' interventions on COPD outcomes. 4
Methods
We conducted a pilot study involving 21 community pharmacists from the province of Quebec, who assessed 82 patients with a diagnosis of either asthma (n = 23) or COPD (n = 59). Participating pharmacists had to work a minimum of 20 hours per week at the pharmacy and they received $50 for each subject recruited. Pharmacists had to complete a brief continuing education lesson on the management of asthma and COPD before the implementation of the program. Pharmacists used a standardized approach to assess patients (see Box 1) . During the assessment, pharmacists reviewed the role of respiratory medication, checked inhalation techniques, assessed disease control/severity, identified potential drug-related problems, evalu-
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Community pharmacy-based medication assessment program for asthma and chronic obstructive pulmonary disease ated medication adherence and completed referrals to an asthma or COPD educator. A summary was provided to each patient's physician with recommendations if appropriate.
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Results
Overall, pharmacists made 59 recommendations (Table 1) . Nine physicians completed and returned a satisfaction questionnaire, and 6 of them reported that the information provided by the pharmacist was very useful (score of 4 or 5 out of 5, 5 being the most useful). Furthermore, all respondents agreed (score of 3 or 4 out of 4, 4 being "completely agree") with the statements that community pharmacists have the expertise "to assess/monitor drug therapy" and "to identify drug-related problems" for COPD patients. Pharmacists generally appreciated the program, but the lack of time was reported to be a barrier. Self-reported time to complete the assessment was about 30 minutes.
Discussion
Lack of time has previously been reported to be a barrier to interventions in asthma by pharmacists. 5, 6 To overcome this barrier, pharmacists could delegate some tasks to pharmacy interns, pharmacy technicians or nurses employed at the pharmacy. n 
